Jonathan Feld

943 total citations
27 papers, 361 citations indexed

About

Jonathan Feld is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jonathan Feld has authored 27 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Jonathan Feld's work include Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Jonathan Feld is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Jonathan Feld collaborates with scholars based in United States and France. Jonathan Feld's co-authors include Dinh Minh Tran, Yuan Kang, Joseph T. Neary, Leonard Naymagon, Alaina J. Kessler, Santiago Thibaud, Douglas Tremblay, Douglas Tremblay, John Mascarenhas and Shyamala Navada and has published in prestigious journals such as Blood, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Jonathan Feld

23 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Feld United States 7 146 92 72 69 62 27 361
Fanny O’Brien United States 15 129 0.9× 30 0.3× 27 0.4× 76 1.1× 384 6.2× 24 818
V. Guerrisi Italy 10 78 0.5× 36 0.4× 69 1.0× 30 0.4× 54 0.9× 10 318
Annalisa Tondo Italy 11 65 0.4× 41 0.4× 140 1.9× 92 1.3× 116 1.9× 36 386
Caleb Cornaby United States 12 42 0.3× 45 0.5× 54 0.8× 88 1.3× 39 0.6× 25 535
Nikolitsa Kafasi Greece 8 61 0.4× 102 1.1× 45 0.6× 100 1.4× 98 1.6× 14 311
Pallavi Khattar United States 8 61 0.4× 23 0.3× 71 1.0× 78 1.1× 24 0.4× 18 260
Sophie Servais Belgium 16 59 0.4× 348 3.8× 109 1.5× 52 0.8× 27 0.4× 47 615
Christine Lombard France 12 57 0.4× 31 0.3× 54 0.8× 72 1.0× 98 1.6× 33 412
Sara Signa Italy 11 24 0.2× 32 0.3× 21 0.3× 77 1.1× 42 0.7× 28 288
Téreza Coman France 12 16 0.1× 210 2.3× 145 2.0× 92 1.3× 23 0.4× 29 501

Countries citing papers authored by Jonathan Feld

Since Specialization
Citations

This map shows the geographic impact of Jonathan Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Feld more than expected).

Fields of papers citing papers by Jonathan Feld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Feld. The network helps show where Jonathan Feld may publish in the future.

Co-authorship network of co-authors of Jonathan Feld

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Feld. A scholar is included among the top collaborators of Jonathan Feld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Feld. Jonathan Feld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Handa, Shivani, Michelle Becker, Jonathan Feld, et al.. (2024). Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights. JCO Precision Oncology. 8(8). e2300234–e2300234. 3 indexed citations
2.
3.
Feld, Jonathan, et al.. (2024). Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis. Clinical Lymphoma Myeloma & Leukemia. 24(10). e385–e391.e1. 2 indexed citations
4.
Sastow, Dahniel, et al.. (2024). Estimating the Prevalence of Possible Undiagnosed Chronic Myelomonocytic Leukemia in the General Population: An Nhanes Analysis. Blood. 144(Supplement 1). 5182–5182. 1 indexed citations
5.
Sastow, Dahniel, Michelle Becker, Jonathan Feld, et al.. (2023). Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement. Leukemia & lymphoma. 64(12). 2002–2007. 4 indexed citations
6.
Sheng, Tianxiang, Dahniel Sastow, Jonathan Feld, et al.. (2023). Array CGH + SNP in ALL Enhances Detection of Complex Cytogenetic Profiles and Suggests That PRSS1 Loss May Play a Role in Leukemogenesis. Blood. 142(Supplement 1). 6062–6062. 1 indexed citations
7.
8.
Sastow, Dahniel, Jonathan Feld, Michal Bar‐Natan, et al.. (2022). Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement. Blood. 140(Supplement 1). 11618–11620. 1 indexed citations
9.
Feld, Jonathan, et al.. (2022). Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future. Leukemia Research. 115. 106820–106820. 3 indexed citations
10.
Tremblay, Douglas, et al.. (2021). Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia. The Oncologist. 26(5). 406–421. 4 indexed citations
11.
Peci, Adriana, et al.. (2021). Decreased hepatitis B and C testing in Ontario, Canada during the first wave of the COVID-19 pandemic. Journal of Hepatology. 75. 1 indexed citations
12.
Rai, Richa, Jonathan Feld, Stella M. Melana, et al.. (2021). Combination of Ras Modulator and Azacitidine Impacts Innate Immune Signaling Pathway in MDS-L Cell Line. Blood. 138(Supplement 1). 4325–4325.
13.
Doroshow, Deborah B., Andrew Schmidt, Ziad Bakouny, et al.. (2020). LBA74 Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS). Annals of Oncology. 31. S1204–S1204. 4 indexed citations
14.
Feld, Jonathan, Shyamala Navada, & Lewis R. Silverman. (2020). Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia. Leukemia Research. 97. 106430–106430. 9 indexed citations
15.
Naymagon, Leonard, Nicole Zubizarreta, Jonathan Feld, et al.. (2020). Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thrombosis Research. 196. 99–105. 83 indexed citations
16.
Tremblay, Douglas, Carina Seah, Thomas Schneider, et al.. (2020). Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients. Cancer Medicine. 9(22). 8571–8578. 32 indexed citations
17.
Feld, Jonathan, Lewis R. Silverman, & Shyamala Navada. (2020). Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases. Clinical Lymphoma Myeloma & Leukemia. 21(4). e415–e422. 4 indexed citations
18.
Feld, Jonathan, Douglas Tremblay, Santiago Thibaud, Alaina J. Kessler, & Leonard Naymagon. (2020). Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. International Journal of Laboratory Hematology. 42(6). 773–779. 48 indexed citations
19.
Feld, Jonathan, et al.. (2019). From CML to Pancytopenia: Case Series of Dasatinib-Induced Aplastic Anemia. Clinical Lymphoma Myeloma & Leukemia. 19. S299–S300.
20.
Neary, Joseph T., Yuan Kang, Dinh Minh Tran, & Jonathan Feld. (2005). Traumatic Injury Activates Protein Kinase B/Akt in Cultured Astrocytes: Role of Extracellular ATP and P2 Purinergic Receptors. Journal of Neurotrauma. 22(4). 491–500. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanny O’Brien Breakdown of academic impact, for papers by V. Guerrisi Breakdown of academic impact, for papers by Annalisa Tondo Breakdown of academic impact, for papers by Caleb Cornaby Breakdown of academic impact, for papers by Nikolitsa Kafasi Breakdown of academic impact, for papers by Pallavi Khattar Breakdown of academic impact, for papers by Sophie Servais Breakdown of academic impact, for papers by Christine Lombard Breakdown of academic impact, for papers by Sara Signa Breakdown of academic impact, for papers by Téreza Coman
Rankless by CCL
2026